USFDA concludes inspection of Biocon’s Oral Solid Dosage formulations manufacturing facility

03 Jun 2023 Evaluate

The United States Food and Drug Administration (USFDA) has concluded a surveillance and pre-approval inspection of Biocon’s subsidiary - Biocon Pharma’s Oral Solid Dosage formulations manufacturing facility at Bengaluru on June 2, 2023. The inspection has been concluded with no observations.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.


Biocon Share Price

366.55 -9.45 (-2.51%)
20-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.00
Dr. Reddys Lab 1166.90
Cipla 1377.85
Zydus Lifesciences 872.95
Lupin 2166.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×